Business Standard

Fosun's sale of Gland Pharma to become India's biggest pharma deal: Report

With the acquisition, Gland pharma may also get access to global companies like AstraZeneca, Sanofi, Mylan, and Organon

Shanghai Fosun Pharmaceutical

Representative Image

BS Web Team New Delhi
Several buyout firms including Advent International, Baring Private Equity Asia, Bain Capital, Blackstone, Carlyle and KKR have been approached to buy Fosun-owned Gland Pharma. If the deal goes forward, it will be India's biggest pharma deal, a report by the Economic Times (ET) said. Currently, Fosun owns a 57.86 per cent stake in the Indian generic injectable maker Gland Pharma.

Fosun acquired Gland Pharma in 2017 for $1.1 billion. It was listed in 2020 in a Rs 6,480 crore IPO. Fosun has appointed Morgan Stanley to find the buyer for the firm. 

In the discussions, the significant control premium sought

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Dec 13 2022 | 3:22 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to